BrokerLens

Nephrocare Health Services Limited IPO (NEPHROPLUS)

Status
Listed
Security type
Mainboard
Price band
Rs.438 to Rs.460
Final issue price
Rs 460
Issue size
Not disclosed
Bidding opens
10 December 2025
Bidding closes
12 December 2025
Listing date
17 December 2025

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Nephrocare Health Services Limited IPO?

The Nephrocare Health Services Limited IPO price band is Rs.438 to Rs.460 per share.

When does the Nephrocare Health Services Limited IPO open and close?

Bidding opens 10 December 2025 and closes 12 December 2025.

Is the Nephrocare Health Services Limited IPO a mainboard or SME issue?

Nephrocare Health Services Limited is a mainboard IPO, listing on NSE's main board.

When did the Nephrocare Health Services Limited IPO list?

Nephrocare Health Services Limited listed on 17 December 2025.

Does this page show the grey market premium (GMP) for Nephrocare Health Services Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Nephrocare Health Services Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.